Third, the nuclear distribution of DUSP6 in CTCs and brain metastases may be prognostic, the majority of metastatic breast cancer patients with brain metastases had cancer cells positive for DUSP6 and all CTCs examined were also DUSP6 positive. Here, DUSP6 is linked to breast carcinoma.